Utah Medical Products Inc
UTMD· Nasdaq
Released Oct 26, 2023, during market hours
10-Q filed Nov 13, 2023, 44 days after period end · 0001811884-23-000021
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $12.51M | $12.96M | $12.57M | $10.48M |
| Net Income | $3.94M | $4.28M | $4.21M | $2.93M |
| EPS Diluted |
Utah Medical Products Inc · CIK 706698 · Engraved from SEC EDGAR
| $1.08 |
| $1.18 |
| $1.15 |
| $0.80 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.